Elizabeth G. O'Farrell
CIK 1744662 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$409.2K
Companies
5
Total Filings
29
Lifetime Open-Market Net
-$149.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNSR | Director | 67,368 | $5.35 | $360.4K | $0 | 8 | 2026-06-05 |
| GERN | Director | 33,627 | $1.45 | $48.8K | $64.3K | 12 | 2026-05-26 |
| SGP | Director | — | $21.62 | — | $0 | 1 | 2026-02-09 |
| IKT | Director | — | $2.31 | — | $0 | 3 | 2022-06-28 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 0 | — | — | -$213.7K | 5 | 2020-11-24 |
Recent Filings · Page 3 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-20 | PDL BIOPHARMA, INC. (PDLI) Delisted | Sell (S) | −63,291 | -$150.7K | EDGAR |
| 2020-08-24 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +25,826 | $0 | EDGAR |
| 2020-08-24 | GERN | Buy (P) | +17,441 | $30.2K | EDGAR |
| 2020-06-09 | GERN | Grant (A) | — | $0 | EDGAR |
| 2020-01-13 | GERN | Buy (P) | +3,000 | $4.0K | EDGAR |
| 2019-06-24 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | GERN | Grant (A) | — | $0 | EDGAR |
| 2019-03-28 | GERN | Grant (A) | — | $0 | EDGAR |
| 2018-06-25 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +63,291 | $150.0K | EDGAR |
Showing 21–29 of 29
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.